- Market Realist•16 hours ago
Johnson & Johnson (JNJ) registered sales of ~$6.2 billion in its Medical Devices segment in 2Q16. The Vision Care business reported the highest growth in the quarter, which came in at ~8.2%.
- Market Realist•17 hours ago
In 3Q16, Johnson & Johnson’s (JNJ) Medical Device segment revenues came in at ~$6.2 billion, compared to $6.1 billion in 3Q15.
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||113.41 x 100|
|Ask||113.67 x 500|
|Day's Range||112.99 - 114.24|
|52wk Range||94.28 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||21.14|
|Avg Vol (3m)||6,128,572|
|Dividend & Yield||3.20 (2.70%)|